Document is current

Any future updates will be listed below

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Crossref DOI link: https://doi.org/10.1186/s12885-017-3539-3

Published Online: 2017-08-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark